Bristol Immunisation Group HIT News
Pfizer’s Vaccine Centre of Excellence launches at the University of Bristol
The Secretary of State for Health and Social Care, the Rt. Hon. Matt Hancock MP,…
Aerosol generating procedures: are they of relevance for transmission of SARS-CoV-2?
Emerging evidence indicates that many currently defined aerosol generating procedures (AGPs) are unlikely to play…
Bristol City Council's webinar tackles the myths and misinformation around the COVID-19 vaccine
On Tuesday, 26 January, 2021, the Bristol City Council Race Equality COVID-19 Steering Group held…
Children needed for STORY study on how immune systems respond to COVID-19
A study looking at how children’s immune systems respond to COVID-19, and to vaccines for…
HIT Conference goes virtual to address the impact of COVID-19 and wider health inequalities
Bristol Health Partners held its annual Health Integration Team (HIT) Conference as an entirely…
Discovery of a druggable pocket in the SARS-CoV-2 Spike protein could stop virus in its tracks
A druggable pocket in the SARS-CoV-2 Spike protein that could be used to stop the…
Bristol Immunisation Group HIT's achievements in 2019-20
Bristol Immunisation Group (BIG) HIT Directors Professor Adam Finn, Dr Julie Yates…
BIG HIT Director coordinates University of Bristol efforts to fight COVID-19
Experts at the University of Bristol have come together to help in the fight against…
Bristol Immunisation Group review of 2018-19
Professor Adam Finn, Dr Julie Yates and Dr Marion Roderick, Directors of the Bristol Immunisation…
HITs secure £2.9 million in research funding in 2018-19
Bristol Health Partners Health Integration Teams (HITs) have attracted nearly £2.9 million in research funding…
Health Integration Teams secure nearly £1.5 million in the first quarter of 2018/19
Bristol Health Integration Teams (HITs) have secured £1,438,000 of funding in the first quarter of…
